High-impact papers
Since 2012, a total of 3 papers are ESI 1% highly cited papers (search date: August 22, 2020)
1. Epidemiology of ovarian cancer: a review (published in 2017, 288 citations)
2. Current approaches in treatment of triple-negative breast cancer (published in 2015, cited 185 times)
3. HOTAIR: an oncogenic long non-coding RNA in different cancers (published in 2015, cited 238 times)
TOP 10 papers cited
The 10 most cited papers since 2012 (search date: August 22, 2020)
1. Epidemiology of ovarian cancer: a review (published in 2017, 288 citations)
2. HOTAIR: an oncogenic long non-coding RNA in different cancers (published in 2015, cited 238 times)
3. Current approaches in treatment of triple-negative breast cancer (published in 2015, cited 185 times)
4. Incidence and mortality of female breast cancer in the Asia-Pacific region (published in 2014, 172 times cited)
5. Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies (published in 2014, cited 159 times)
6. PI3K/Akt/mTOR inhibitors in breast cancer (published in 2015, cited 116 times)
7. Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy (published in 2014, cited 101 times)
8. pH-responsive mesoporous silica nanoparticles employed in controlled drug delivery systems for cancer treatment (published in 2014, cited 93 times)
9. Colorectal cancer carcinogenesis: a review of mechanisms (published in 2016, cited 88 times)
10. Mechanistic considerations for the use of monoclonal antibodies for cancer therapy (published in 2014, cited 81 times)
No comments:
Post a Comment